Description
Register/Registration for
the MajesTEC-9 study
If you meet these CRITERIA talk to us about being part of a clinical trial:
– aged 18 or older
– Have recurrent or treatment-resistant multiple myeloma
– Have had 1-3 prior treatments for multiple myeloma and at least 2 consecutive cycles of Daratumumab (anti CD38 monoclonal antibody) and Lenalidomide in prior lines
The study team will share the other criteria with you.